APA (7th ed.) Citation

MacGregor, T., Carter, R., Gillies, R., Findlay, J., Kartsonaki, C., Castro-Giner, F., . . . Sharma, R. (2018). Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

MacGregor, T., et al. Translational Study Identifies XPF and MUS81 as Predictive Biomarkers for Oxaliplatin-based Peri-operative Chemotherapy in Patients with Esophageal Adenocarcinoma. Nature Publishing Group, 2018.

MLA (9th ed.) Citation

MacGregor, T., et al. Translational Study Identifies XPF and MUS81 as Predictive Biomarkers for Oxaliplatin-based Peri-operative Chemotherapy in Patients with Esophageal Adenocarcinoma. Nature Publishing Group, 2018.